Golimumab for the Treatment of Psoriatic Arthritis: A NICE Single Technology Appraisal

Author： Yang Huiqin  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.30, Iss.4, 2012-04, pp. : 257-270

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dronedarone for the Treatment of Atrial Fibrillation: A NICE Single Technology Appraisal

By McKenna Claire  

PharmacoEconomics, Vol. 30, Iss. 1, 2012-01 ,pp. : 35-46

Adis International

Access to resources Recommend Favorite

Golimumab grabs the limelight in psoriatic arthritis

By  

Inpharma, Vol. 1, Iss. 1616, 2007-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Omalizumab for the Treatment of Severe Persistent Allergic Asthma in Children Aged 6-11 Years: A NICE Single Technology Appraisal

By Burch Jane  

PharmacoEconomics, Vol. 30, Iss. 11, 2012-11 ,pp. : 991-1004

Adis International

Access to resources Recommend Favorite

Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal

By Boyers Dwayne  

PharmacoEconomics, Vol. 30, Iss. 6, 2012-06 ,pp. : 483-495

Adis International

Access to resources Recommend Favorite

Golimumab: a guide to its use in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 4, 2010-04 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite